Skip to main content
Erschienen in: Clinical and Translational Oncology 10/2015

01.10.2015 | Research Article

Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma

verfasst von: Y. Zhang, C. Jiang, J. Li, J. Sun, X. Qu

Erschienen in: Clinical and Translational Oncology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) were immune response-related indicators. Preoperative NLR and PLR had been considered to be related to the prognosis of various cancers. The objective of this study was to evaluate the prognostic significance of NLR and PLR in patients with gallbladder carcinoma (GBC).

Methods

From 2001 to 2013, 145 patients with GBC were recruited in this retrospective study. Cutoff values of NLR and PLR were determined by receiver operating characteristic curves (ROC). The correlation of clinical data, including tumor differentiation, nevin stage, TNM stage, operation margin, operation mode, NLR, PLR, hemoglobin, C reactive protein (CRP), carcinoembryonic antigen (CEA), and carbohydrate antigen 199 (CA199) with median survival period of patients was analyzed by univariate survival analysis. The multivariate prognosis analysis was performed to select the independent prognostic factors.

Results

The cutoff values of NLR and PLR were 1.94 and 113.34, respectively. Compared with low NLR and low PLR group, the 5-year survival rates in high NLR and high PLR group were reduced (P < 0.05). The degree of tumor differentiation, nevin stage, TNM stage, operation mode, NLR, PLR, CA199, total bilirubin, CRP and CEA were associated with the median survival period of patients (P < 0.01). The multivariate prognosis analysis showed that NLR, nevin stage, operation mode and hemoglobin were independent prognostic factors (P < 0.05).

Conclusion

Preoperative NLR and PLR were closely related to prognosis of patients with GBC and might be useful for the evaluation of prognosis of patients with GBC.
Literatur
1.
Zurück zum Zitat Liu Y, He X, Wang J, Li J, Li K, Liu F et al. Establishment of liver metastasis model of human gallbladder cancer and isolation of the subpopulation with high metastatic potential. Zhonghua yi xue za zhi. 2006;86:2117–21.PubMed Liu Y, He X, Wang J, Li J, Li K, Liu F et al. Establishment of liver metastasis model of human gallbladder cancer and isolation of the subpopulation with high metastatic potential. Zhonghua yi xue za zhi. 2006;86:2117–21.PubMed
2.
Zurück zum Zitat Butte JM, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Allen PJ et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50–61.CrossRefPubMed Butte JM, Matsuo K, Gönen M, D'Angelica MI, Waugh E, Allen PJ et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50–61.CrossRefPubMed
3.
Zurück zum Zitat Haq N, Khan BA, Imran M, Akram A, Jamal AB, Bangash F. Frequency of gall bladder carcinoma in patients with acute and chronic cholecystitis. J Ayub Med Coll Abbottabad. 2014;26:191.PubMed Haq N, Khan BA, Imran M, Akram A, Jamal AB, Bangash F. Frequency of gall bladder carcinoma in patients with acute and chronic cholecystitis. J Ayub Med Coll Abbottabad. 2014;26:191.PubMed
4.
Zurück zum Zitat Miller G, Jarnagin W. Gallbladder carcinoma. Eur J Surg Oncol (EJSO). 2008;34:306–12.CrossRef Miller G, Jarnagin W. Gallbladder carcinoma. Eur J Surg Oncol (EJSO). 2008;34:306–12.CrossRef
5.
Zurück zum Zitat Bartlett DL, Fong Y, Fortner JG, Brennan MF, Blumgart LH. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224:639.PubMedCentralCrossRefPubMed Bartlett DL, Fong Y, Fortner JG, Brennan MF, Blumgart LH. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224:639.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, et al. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol. 2014;21:449–57.CrossRefPubMed Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu WG, Cao Y, et al. Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma. Ann Surg Oncol. 2014;21:449–57.CrossRefPubMed
7.
Zurück zum Zitat Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K et al. The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC cancer. 2013;13:52.PubMedCentralCrossRefPubMed Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K et al. The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma. BMC cancer. 2013;13:52.PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19:217–24.CrossRefPubMed Azab B, Bhatt VR, Phookan J, Murukutla S, Kohn N, Terjanian T et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients. Ann Surg Oncol. 2012;19:217–24.CrossRefPubMed
9.
Zurück zum Zitat Duan H, Zhang X, Wang F-X, Cai M-Y, Ma G-W, Yang H et al. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. World J Gastroenterol. 2015;21:5591.PubMedCentralCrossRefPubMed Duan H, Zhang X, Wang F-X, Cai M-Y, Ma G-W, Yang H et al. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. World J Gastroenterol. 2015;21:5591.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Gao F, Li X, Geng M, Ye X, Liu H, Liu Y et al. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine. 2015;94:e639.CrossRefPubMed Gao F, Li X, Geng M, Ye X, Liu H, Liu Y et al. Pretreatment neutrophil-lymphocyte ratio: an independent predictor of survival in patients with hepatocellular carcinoma. Medicine. 2015;94:e639.CrossRefPubMed
11.
Zurück zum Zitat Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS One. 2015;10. Fan W, Zhang Y, Wang Y, Yao X, Yang J, Li J. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolization. PLoS One. 2015;10.
12.
Zurück zum Zitat Nevin JE, Moran TJ, Kay S, King R. Carcinoma of the gallbladder. Staging, treatment, and prognosis. Cancer. 1976;37:141–8.CrossRefPubMed Nevin JE, Moran TJ, Kay S, King R. Carcinoma of the gallbladder. Staging, treatment, and prognosis. Cancer. 1976;37:141–8.CrossRefPubMed
13.
Zurück zum Zitat Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncology. 2010;17:1471–4.CrossRefPubMed Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncology. 2010;17:1471–4.CrossRefPubMed
14.
Zurück zum Zitat Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71:2411–6.CrossRefPubMed Gregory AD, Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011;71:2411–6.CrossRefPubMed
15.
Zurück zum Zitat Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci. 2012;109:13076–81.PubMedCentralCrossRefPubMed Demers M, Krause DS, Schatzberg D, Martinod K, Voorhees JR, Fuchs TA, et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci. 2012;109:13076–81.PubMedCentralCrossRefPubMed
16.
Zurück zum Zitat Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21:137–48.CrossRefPubMed Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21:137–48.CrossRefPubMed
17.
Zurück zum Zitat Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32:22–8.CrossRefPubMed Fogar P, Sperti C, Basso D, Sanzari MC, Greco E, Davoli C, et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas. 2006;32:22–8.CrossRefPubMed
18.
Zurück zum Zitat Adamek M, Kawczyk-Krupka A, Mostowy A, Czuba Z, Krol W, Kasperczyk S, Jakobisiak M, et al. Topical ALA-PDT modifies neutrophils’ chemiluminescence, lymphocytes’ interleukin-1beta secretion and serum level of transforming growth factor beta1 in patients with nonmelanoma skin malignancies: a clinical study. Photodiagnosis Photodyn Ther. 2005;2:65–72.CrossRefPubMed Adamek M, Kawczyk-Krupka A, Mostowy A, Czuba Z, Krol W, Kasperczyk S, Jakobisiak M, et al. Topical ALA-PDT modifies neutrophils’ chemiluminescence, lymphocytes’ interleukin-1beta secretion and serum level of transforming growth factor beta1 in patients with nonmelanoma skin malignancies: a clinical study. Photodiagnosis Photodyn Ther. 2005;2:65–72.CrossRefPubMed
19.
Zurück zum Zitat Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.
20.
Zurück zum Zitat Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123–34.CrossRefPubMed Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123–34.CrossRefPubMed
21.
Zurück zum Zitat Takagi S, Sato S, Oh-hara T, Takami M, Koike S, Mishima Y, et al. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2. PLoS One. 2013;8:e73609.PubMedCentralCrossRefPubMed Takagi S, Sato S, Oh-hara T, Takami M, Koike S, Mishima Y, et al. Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2. PLoS One. 2013;8:e73609.PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Cho MS, Bottsford-Miller J, Vasquez HG, Stone R, Zand B, Kroll MH, et al. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012;120:4869–72.PubMedCentralCrossRefPubMed Cho MS, Bottsford-Miller J, Vasquez HG, Stone R, Zand B, Kroll MH, et al. Platelets increase the proliferation of ovarian cancer cells. Blood. 2012;120:4869–72.PubMedCentralCrossRefPubMed
23.
Zurück zum Zitat Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13:499–503.CrossRefPubMed Asher V, Lee J, Innamaa A, Bali A. Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer. Clin Transl Oncol. 2011;13:499–503.CrossRefPubMed
24.
Zurück zum Zitat Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014 (cebp. 0146). Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014 (cebp. 0146).
25.
Zurück zum Zitat Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149–63.CrossRefPubMed Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6:149–63.CrossRefPubMed
26.
Zurück zum Zitat Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol. 2008;98:540–4.CrossRefPubMed Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, et al. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer. J Surg Oncol. 2008;98:540–4.CrossRefPubMed
27.
Zurück zum Zitat Jagdev S, Gregory W, Vasudev N, Harnden P, Sim S, Thompson D, et al. Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. Br J Cancer. 2010;103:1649–56.PubMedCentralCrossRefPubMed Jagdev S, Gregory W, Vasudev N, Harnden P, Sim S, Thompson D, et al. Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein. Br J Cancer. 2010;103:1649–56.PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Yokoyama Y, Ebata T, Igami T, Sugawara G, Ando M, Nagino M. Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection. Surgery. 2014;155:504–11.CrossRefPubMed Yokoyama Y, Ebata T, Igami T, Sugawara G, Ando M, Nagino M. Predictive power of prothrombin time and serum total bilirubin for postoperative mortality after major hepatectomy with extrahepatic bile duct resection. Surgery. 2014;155:504–11.CrossRefPubMed
29.
Zurück zum Zitat Nomura S, Watanabe M, Komine O, Shioya T, Toyoda T, Bou H, et al. Serum total bilirubin elevation is a predictor of the clinicopathological severity of acute appendicitis. Surg Today. 2014;44:1104–8.CrossRefPubMed Nomura S, Watanabe M, Komine O, Shioya T, Toyoda T, Bou H, et al. Serum total bilirubin elevation is a predictor of the clinicopathological severity of acute appendicitis. Surg Today. 2014;44:1104–8.CrossRefPubMed
Metadaten
Titel
Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma
verfasst von
Y. Zhang
C. Jiang
J. Li
J. Sun
X. Qu
Publikationsdatum
01.10.2015
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 10/2015
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-015-1310-2

Weitere Artikel der Ausgabe 10/2015

Clinical and Translational Oncology 10/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.